Amelia S. Petry

518 total citations
9 papers, 423 citations indexed

About

Amelia S. Petry is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Amelia S. Petry has authored 9 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Amelia S. Petry's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Amelia S. Petry is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Amelia S. Petry collaborates with scholars based in United States and New Zealand. Amelia S. Petry's co-authors include John A. Wagner, Julie A. Stone, Larissa Wenning, Marian Iwamoto, Keith Gottesdiener, Eric Mangin, William D. Hanley, Diana M. Brainard, Kalyan Ghosh and Sheila Breidinger and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Amelia S. Petry

9 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amelia S. Petry United States	7	367	209	119	78	64	9	423
Rosa Ruiz-Valderas Spain	12	342 0.9×	160 0.8×	189 1.6×	52 0.7×	46 0.7×	26	457
Andrew Luber United States	9	315 0.9×	167 0.8×	120 1.0×	40 0.5×	28 0.4×	22	395
L. Trentini Italy	11	257 0.7×	137 0.7×	78 0.7×	53 0.7×	63 1.0×	25	354
Gema González‐Pardo Spain	7	348 0.9×	169 0.8×	128 1.1×	97 1.2×	81 1.3×	9	454
Yoninah Cramer United States	9	211 0.6×	98 0.5×	130 1.1×	36 0.5×	26 0.4×	17	345
Magda Opsomer Belgium	12	422 1.1×	293 1.4×	78 0.7×	41 0.5×	51 0.8×	29	517
Megan Neary United Kingdom	10	196 0.5×	63 0.3×	69 0.6×	59 0.8×	19 0.3×	25	267
Lorant Leopold United States	9	500 1.4×	347 1.7×	258 2.2×	28 0.4×	42 0.7×	14	663
Annemie Buelens Belgium	10	268 0.7×	93 0.4×	234 2.0×	36 0.5×	222 3.5×	19	438
Stephan Klauke Germany	10	252 0.7×	201 1.0×	75 0.6×	15 0.2×	49 0.8×	24	332

Countries citing papers authored by Amelia S. Petry

Since Specialization

Citations

This map shows the geographic impact of Amelia S. Petry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelia S. Petry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelia S. Petry more than expected).

Fields of papers citing papers by Amelia S. Petry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelia S. Petry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelia S. Petry. The network helps show where Amelia S. Petry may publish in the future.

Co-authorship network of co-authors of Amelia S. Petry

This figure shows the co-authorship network connecting the top 25 collaborators of Amelia S. Petry. A scholar is included among the top collaborators of Amelia S. Petry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelia S. Petry. Amelia S. Petry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Strizki, Julie, Richard J. O. Barnard, Carolyn McHale, et al.. (2012). 1208 EVALUATION OF NS3 AMINO ACID VARIANTS IN A PHASE 1B STUDY OF GENOTYPE 1 (GT1) AND GT3 INFECTED PATIENTS WITH THE HCV PROTEASE INHIBITOR, MK-5172. Journal of Hepatology. 56. S479–S479. 4 indexed citations

Brainard, Diana M., Kelem Kassahun, Larissa Wenning, et al.. (2010). Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation. The Journal of Clinical Pharmacology. 51(6). 943–950. 29 indexed citations

Petry, Amelia S., Diana M. Brainard, Kristien Van Dyck, et al.. (2010). Safety and Antiviral Activity of MK-5172, a Novel HCV NS3/4a Protease Inhibitor with Potent Activity Against Known Resistance Mutants, in Genotype 1 and 3 HCV-Infected Patients. 27 indexed citations

Iwamoto, Marian, William D. Hanley, Amelia S. Petry, et al.. (2009). Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 53(5). 1747–1752. 37 indexed citations

Wenning, Larissa, William D. Hanley, Diana M. Brainard, et al.. (2009). Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir. Antimicrobial Agents and Chemotherapy. 53(7). 2852–2856. 127 indexed citations

Petry, Amelia S.. (2008). Raltegravir (RAL) Pharmacokinetics in Individuals with UGT1A1*1/*1 and UGT1A1*28/*28 Genotypes. 46th Annual Meeting. 2 indexed citations

Iwamoto, Marian, Larissa Wenning, Goutam C. Mistry, et al.. (2008). Atazanavir Modestly Increases Plasma Levels of Raltegravir in Healthy Subjects. Clinical Infectious Diseases. 47(1). 137–140. 74 indexed citations

Iwamoto, Marian, Larissa Wenning, Amelia S. Petry, et al.. (2008). Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir. Antimicrobial Agents and Chemotherapy. 52(12). 4338–4343. 53 indexed citations

Iwamoto, Marian, Kelem Kassahun, Matthew D. Troyer, et al.. (2007). Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo Correlation. The Journal of Clinical Pharmacology. 48(2). 209–214. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact